Researchers have created new nanomaterials able to cross cell membranes, establishing a novel platform for the intracellular delivery of molecular drugs and other cargo.
Researchers are paving the way toward a new therapeutic approach for gonorrhea by shedding light on the mechanism behind important proteins on the Neisseria gonorrhoeae bacteria’s outer membrane.
The Linus Pauling Institute will host its biennial “Diet and Optimum Health” conference Sept. 13-16, attracting an international audience of experts in nutrition, preventive medicine and oncology.
Oregon State University has named Richard van Breemen as the director of the university’s Linus Pauling Institute.
Dan Arp, dean of the College of Agricultural Sciences, and Mark Zabriskie, dean of the College of Pharmacy, will step down from these university leadership roles effective June 30, 2018.
Researchers have identified a possible new treatment for gonorrhea, using a peptide that thwarts the infection-causing bacterium by interfering with an enzyme the microbe needs to respirate.
Research suggests patients nearing the end of their lives because of a “life-limiting illness” may not feel medically abandoned if their doctor wants to take them off cholesterol medicine.
Research suggests the bacteria that cause TB alter their metabolism to combat exposure to antimicrobials, and that the metabolic mechanisms might be neutralized by new drugs.
A new cancer-drug delivery system shows the ability to exploit the oxygen-poor areas of solid tumors that make the growths resistant to standard chemotherapy and radiation treatment.
Researchers have made a fundamental advance in dermatology that could lead to new therapies for millions of people with atopic dermatitis, one of the most common forms of eczema.
Grab a feed of news and stories for your site.